AIC
COYA icon

AWM Investment Company’s Coya Therapeutics COYA Stock Holding History

AWM Investment Company’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-725,000
Closed -$4.21M – 103
2025
Q4 		$4.21M Buy
+725,000
New +$4.41M 0.41% 65

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

AWM Investment Company's COYA Position: Q1 2026 in Review

AWM Investment Company sold out of Coya Therapeutics (COYA) in Q1 2026, closing a stake of 725,000 shares — an estimated $4.21M sold.

AWM Investment Company first reported a position in COYA in Q4 2025 and held it in 1 quarter. The position peaked at $4.21M in Q4 2025. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • AWM Investment Company reported no remaining Coya Therapeutics position as of Q1 2026 after selling out during the quarter.
  • AWM Investment Company sold 725,000 Coya Therapeutics shares in Q1 2026, an estimated $4.21M.
  • AWM Investment Company first reported a position in Coya Therapeutics in Q4 2025 and held it in 1 quarter.
  • AWM Investment Company's Coya Therapeutics position peaked at $4.21M in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.